Lorillard
Current Digest of Scientific Papers Relating to Tobacco Use
Fields
- Alias
- 03663140/03663173
- Type
- PUBL, OTHER PUBLICATION
- ABST, ABSTRACT
- Area
- LEGAL DEPT FILE ROOM
- Site
- N14
- Request
- R1-004
- R1-037
- R1-039
- R1-040
- R1-041
- R1-042
- R1-045
- R1-046
- R1-048
- R1-060
- R1-071
- R1-073
- R1-088
- R3-005
- R1-037
- Copied
- Stevens, A.J.
- Date Loaded
- 05 Jun 1998
- Master ID
- 03662523/3441
Related Documents:- 03662523 Tobacco Industry Council for Tobacco Research Usa -- Research Matters Vol. 2 - 710000
- 03662524-2525
- 03662526
- 03662527 Untitled Document 03662527
- 03662528-2531 Current Status of Ctr's Consideration of Microbiological Associates Contract Proposals
- 03662532-2538 Ctr-Supported Researches: 770000
- 03662539-2545 Expenditures Against 770000 Budget and Estimate for 780000
- 03662546-2547 Untitled Document 03662546/2547
- 03662548-2554 the Rationale for Nicotine or Smoking Studies in Relation to the Central Nervous System (Cns).
- 03662555-2557 Summary of Ctr Meeting 771122
- 03662558 Research Information Review 771122
- 03662559-2566 Prospectives for Ctr in Relation to Cns Studies
- 03662567
- 03662568
- 03662569-2571
- 03662573-2575
- 03662576
- 03662577-2578 Untitled Document 03662577/2578
- 03662579-2580 Bap Experiments
- 03662582-2583
- 03662584-2585
- 03662587-2588
- 03662589
- 03662590-2592 14 New Studies Funded by Tobacco Research Council
- 03662593-2594
- 03662595
- 03662597-2598
- 03662599-2600 Ctr Meeting - 750514 - 750515 (Your Memo of 750416)
- 03662601
- 03662602
- 03662603
- 03662606 Untitled Document 03662606
- 03662607 Notice of Special Meeting of the Board of Directors to Be Held 741205
- 03662608-2609
- 03662610
- 03662611-2612
- 03662613
- 03662613A Professor Is Awarded Leaf Grant
- 03662613B
- 03662614-2615 the Cancer Newsletter
- 03662616-2618 Tobacco Research Group Announces New Studies
- 03662619-2621 Massive Cancer Study Using Made-to-Order Mice
- 03662622-2626 Ctr Report Meeting 740522
- 03662627 Grants and Contracts Meeting 740522
- 03662633-2643 Staff Report Oak Ridge National Laboratories
- 03662644-2645 Noted Pathologist Joins Scientific Advisory Board
- 03662646
- 03662647-2648
- 03662649
- 03662650
- 03662653
- 03662654-2655
- 03662656
- 03662657-2659
- 03662660
- 03662662
- 03662663-2664
- 03662665
- 03662666-2669
- 03662670-2673 Chronology of Events
- 03662674 Untitled Document 03662674
- 03662675-2676 Untitled Document 03662675/2676
- 03662678
- 03662679 Dup of Id 03662665
- 03662680-2683
- 03662684-2687 Chronology of Events
- 03662689
- 03662690-2691
- 03662692
- 03662693
- 03662694
- 03662695-2696
- 03662697
- 03662698
- 03662699
- 03662700
- 03662701-2702 Noted Cancer Scientist Named Scientific Director of the Council for Tobacco Research
- 03662703 Gaps in Knowledge
- 03662704-2717 Sub-Committee Report
- 03662718-2728 Tobacco and Health Research Some Proposed
- 03662729-2730
- 03662731 C.T.R. - S.A.B.
- 03662732
- 03662733-2737 Meeting of Scientific Advisory Board of the Council for Tobacco Research 730314 New York, N.Y.
- 03662738
- 03662739
- 03662740
- 03662741 Your Reference: 527/111
- 03662742-2743
- 03662744-2746 Progress in Tobacco Health Research Achieved: Machines That Simulate Human Smoking
- 03662747-2748
- 03662749-2751 New Smoking Health Studies Boost Total to $23-Million
- 03662752
- 03662754
- 03662757
- 03662758-2761 Minutes of the Meeting of the Board of Directors 721110
- 03662762-2765 Summary on Work Sponsored by the Council for Tobacco Research on the Effect of Nicotine and Smoking on the Cardiovascular System
- 03662766-2768 Research Program Summary (Confidential)
- 03662769 Proposed Resolution Relating to Authority of Scientific Director in Approval of Grants and Contracts for Research to Be Funded Out of Regular Research Budget
- 03662770-2776 Current Status and Progress of the Research Program
- 03662777-2782 Research Program Projection
- 03662802
- 03662803
- 03662804-2808
- 03662809
- 03662810
- 03662811
- 03662813
- 03662814
- 03662815-2820 Memorandum Concerning Proposed Contract with Oak Ridge National Laboratory for Developing Methodology and Evaluating Smoking Devices for Use in Biological Experiments.
- 03662821-2824 Ctr-Lorillard 000815 - at 200 E42
- 03662825-2826
- 03662827-2828
- 03662830
- 03662831-2836 Draft Suggestion for C.T.R. Role
- 03662837
- 03662838 Council for Tobacco Research
- 03662839
- 03662840-2841 Lorillard Proposal with Respect to Long-Range and Specific Planning for Ctr Research Activities
- 03662843
- 03662844-2846
- 03662847-2848
- 03662849-2852 New Scientific Findings About Cancer, Heart Disease, the Lung, Other Areas, Reported by Council for Tobacco Research
- 03662853
- 03662854
- 03662857-2858 C.T.R.
- 03662859
- 03662860 Your Note of 720320
- 03662861
- 03662864
- 03662865
- 03662866-2867 Lorillard Proposal with Respect to Long-Range and Specific Planning for Ctr Research Activities
- 03662868 22-Year-Old Heart Study Saved After U.S. Fund Cut
- 03662868A
- 03662869
- 03662870
- 03662871-2873 Untitled Document 03662871/2873
- 03662875-2876
- 03662877-2879 New Tobacco-Health Grants Announced, One Helps Revive Framingham Heart Study
- 03662880
- 03662882
- 03662883-2884 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662885-2889 Significant Smoking-Health Findings Covered in Report by Dr. C.C. Little
- 03662890-2901 the Council for Tobacco Research-Usa Inc
- 03662902 Tobacco Industry Council for Tobacco Research - Usa Current Digests
- 03662904-2943 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662944-2969 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662970-2993 Current Digest of Scientific Papers Relating to Tobacco Use
- 03662994-3021 Current Digest - Author's Index
- 03663022-3061 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663062-3099 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663100-3139 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663174-3211 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663212-3253 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663254-3287 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663288-3333 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663334-3371 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663372-3407 Current Digest of Scientific Papers Relating to Tobacco Use
- 03663408-3441 Current Digest of Scientific Papers Relating to Tobbacco Use
- Author (Organization)
- Current Digest of Scientific Papers
- Litigation
- Stmn/Produced
- Characteristic
- MINI, MINIMUM CODING
- UCSF Legacy ID
- qci71e00
Document Images
CURRENT DIGEST
(
of Scientific Papers Relating to Tobacco Use
(Compiled and Described for Ilnformational Purposes Only for The Council for Tobacco
Research-U.S:A., Inc. The Summaries Are Not Internded to be Complete Scientific Abstracts.)I
Vol. 28, No. 10.
Contents October 1983
Page
1. Heart and Circulation 1
2. Respiratory Conditions 2
3. Pregnancy 5
4. Other Systemic Conditions 7
5. Statistics 9_
6. Nicotine 10
7. Smoke Condensate and Constituents 14
8. Smoking Habits 18
9. Briefs from Meetings 20.
10. Additional References 31
C
1. HEART & CIRCULATION
PETITTI, D.B., & KLATSKY, A.L., Kaiser-Permanente Medical Care Program,
Oakland, California
"Malignant hypertension in women aged!15 to 44 years and its relation to
cigarette smoking and oral contraceptives." (American Journal of Cardiology
52/3: 297-8, August 1983)
"To study the factors associated with malignant hypertension in
young women~, we reviewed the medical records of all women aged 15 to 44 years
who were hospitalized in any of 15 affiliated hospitals from 1971 to 1980 with
malignant hypertension. There were 15 new patients in this period!, an inci-
dence of 0.5 per 100,000 women of these ages per year. Four women~had under-
lying renal disease. All of the remaining 11 use&oral contraceptives, smoked
cigarettes, or both. Nine were white, and16 women had normal blood'.pressure
in the 24 months before hospitalization. These findings support a relation of
oral contraceptive use and cigarette smoking to an~increasedlrisk of malignant
hypertension in young women."
C
FRIEDMAN, Cs.D., FIREMAN, B.H., RETITTI, D.B., SIEGELAUiB, A.B., URY, H.K. &
KLATSKY, A.L., Kaiser-Permanente Medical Care Program, Oakland, California
"Psychological questionnaire score, cigarette smoking, and myocardial in,
farction: A continuing enigma." (Preventive Medicine 12/4: 533-40, July 1983)
~ "The ability of a group of 94 psychological questions to discrim-
inate between men in whom cigarette smoking was associated with increased risk
of myocardial infarction and men in whom~smoking was not so associated remains
C.W
~
W
IN
W~+
'J

2.
d
puzzling. Further anal!yses, controlling for reported alcohol consumption and
for a questionnaire item that might reflect physical activity, failed to alter
this finding. This interaction of the questionnaire responses with smoking
was not found with two other major coronary risk factors, serum cholesterol
and systolic bloodipressure. Believing that these observations may provide
(a) a clue to how cigarette smoking affects risk of myocardial infarction,
or (b) some means.of identifying greater or lesser susceptibility to the
effects of smoking, we invite other investigators to join in the pursuit
of this matter. A list of ten selected yes-or-no questions with strong
interaction with smoking is provided!to assist others in studying this
phenomenon~; these are similar to ten items on the Minnesota Multiphasic
Personality Inventory."
DOWNEY, H.F., CRYSTAL, G.J. & BASHOUR, F.A., University of Texas Health
Science Center, Dallas (CTR-grant)
"Regional myocardial blood flow during nicotine infusion after chronic coronary
artery occlusion: Effect of :-adrenergic blockade."' (Journal of Cardlo-
vascular Pharmacology 5/4: 685-90, 1983)
"In eight dogs a portion of the left ventricular free wall (LVFW)
was rendered collateral-dependent (CD) by gradual occlusion of the left
anterior descending coronary artery with a surgically implante&Ameroid~con-
strictor. Six to 8 weeks later, the dogs were anesthetized an6regi.onal myo-
cardial blood flow was measured with 7-10-..,-.m radioactive microspheres during
(a) control conditions, (b) nicotine alone (24 ctg/kg/min i.v.), and (c) nic-
otine (24 ug/kg/min i.v.) after 5 -adrenergir blockade with propranolol.
During control conditions, mean transmural flow was similar in CD, border, and
normal regions of the LVFW. Nicotine alone increased flow in all regions of
the LVFW, with normal (+ 104%) greater than CD (+ 56%). These changes in flow
were accompanied by increases in mean arterial pressure (+ 34%) and mean
aortic flow (+ 54%). Nicotine after ,-,-adrenergic blockade appreciably raise&
mean arterial pressure (+ 83%) and mean left atrial pressure (+ 307%), but
caused no increase in flow to any region of the LVFW. The results indicate
(a) that the nicotine-induced increase in flow is blunted in a CD region, and
that (b).;-adrenergic blockade unmasks coronary vasoconstrictor mechanisms
during nicotine infusion which prevent increases in flow to either normal or
CD regions despite increased perfusion pressure and augmented myocardial oxygen
demands."
2. RESPIRATORY CONDITIONS
CORREA, P., PICKLE, L.W., FONTHAM, E., LIN, Y. & HAENSZEL, W., Louisiana State
University Medical Center, New Orleans
"Passive smoking and lung cancer." (Lancet I'I: 595-7, September 10, 1983)
"Questions about the smoking habits of parents and spouses were askedi
in~a case-control study involving 1338 lung cancer patients and 1393 com-
parison subjects in Louisiana, USA. Non-smokers marriedito heavy smokers had
an increased risk of lung cancer, and so did subjects whose motherfi smokedl.
There was no associationibetweenilung cancer risk and paternal smoking. The
association with maternal smoking was found only in smokers and persisted,
after controlling for variables indicative of active smoking....
C
(
c

3.
C
<
"Our findings indicate that maternal smoking,results in a slight in-
crease in lung,cancer risk but do not indicate whether the effect is due to
enhanced active smoking of the offspring or to enhanced susceptibility to lung
cancer inductiion after the challenge of active smoking,later in life.
"Our findings point to the need for more research on the subject of
passive smoking,and cancer. Since large numbers of cases may be needed for
adequate epidemiological analysis, multi-institutional collaboration may be
indicated!."
STONE, P.J., CALORE, J.D., McGOWAN, S.E., BERNARDO, J., SNIDER, G.L. &
FRANZBLAU!, C., Boston University S'chool of Medicine, Massachusetts
"Functional _-,`1-protease inhibitor in the lower respiratory tract of cig-
arette smokers is not decreased." (Science 221: 1187-9, September 16, 1983)
"Cigarette smoking is the major risk factor for the development of
pulmonary emphysema, a disorder that may result from an imbalance between the
elastase and antielastase levels in the lungs. Decreased functional "~l-pro-
tease inhibitor, an inhibitor of neutrophil elastase, might render smokers
susceptible to elastase-catalyzed destruction of pulmonary elastic fibers
and'the development of emphysema. Binding and inactivation of isotopically
labeled porcine pancreatic elastase and human neutrophil elastase by '1-pro-
tease inhibitor were measured in fluid obtained by bronchoalveolar lavage of
volunteers. The inhibition of elastase-catalyzed solubilization of elastin
and'a tripeptide substrate were also determined. The mean~level of functional
~1-protease inhibitor in the bronchoalveolar lavage fluid of smokers was
found to be equal to or greater than that of nonsmokers, contradicting reports
by other investigators. Increased elastase derived'from~pulmonary neutro-
phils, rather than decreased functional ~1-protease inhibitor, appears to be
the main factor in the genesis of emphysema in smokers."
[N = 21 smokers, 16 nonsmokers]
ABBOUD, R.T., JOHNSON, A.J., RICHTER, A.M. & ELWOOD, R.K., Vancouver General
Hospital, Canada
"C'omparison~of in vitro neutrophil elastase release in nonsmokers and smokers."
(American R'eview of Respiratory Disease 128/3: 507-10, September 1983)
"Protease-antiprotease imbalance in the lung is considered.a likely
pathogenetic mechanism in the development of emphysema. To assess whether
differences in enzyme release from~stimulatedlneutrophils could be a factor
leading to increased elastase release in the lung, we compared the in vitro
release of elastase and a lysosomal enzyme, 1"-gllucosaminidase, from neutro-
phils of nonsmokers and smokers. Neutrophils were stimulated in vitro by
zymosan as a phagocytic stimulus, and the synthetic polypeptide, N-formyl-
methionyl-lieucyl-phenyl-alanine (FMLP) as chemotactic factor. We studied 54
male subjects, 24 nonsmokers (mean age, 39.5 + SD 14.4!yr) and 30 smokers
(mean age, 45.4!+ SD 8.2 yr). Smokers were divided into 2 groups according
to results of their lung function, 17 with normal and 13 with abnormal lung
function. Smokers with abnormal lung function were older (59.8 + SD 11.8 yr)
i

4.
and had smoked more (45.6 + SD 18.2 pack-years), than smokers withinormal
lung function (mean age, 39.8 + SD 11.0 yr; smoking, 22.1 + SD 19'.4 pack-
years). There were no differences in either -glucosamimidase or elastase
release after either zymosan or FMLP stimulation among the 3 groups of
subjects; there were also no significant differences in the content of these
enzymes in whole cell neutrophil lysates. Our data indicate that chronic
smoking did not affect neutrophil elastase release inivitro, and that among
smokers there was no significant relationship betweenin vitro neutrophil
elastase release and abnormalities in lung function, suggesting that in-
herent differences in elastase release from stimulated'.neutsophils are not
likely to be of pathogenetic importance in leading to abnormal lung,function
in smokers.'°
DAVIES, S.F., OFFORD, K.P., BROWN, M.G., CAMPE', H. & NIEWOEHNER, D.,
U'niversity of Minnesota Medical School, Minneapolis
"Urine desmosine is unrelated to cigarette smoking or to spirometric
function." (American Review of Respiratory Disease 128/3: 473-5, September
1983)
"We measured urine desmosine by radioimmunoassay in 157 subjects.
Desmosine excretion (expressed as desmosine/creatinine ratio) did not cor-
relate with ventilatory function (assessed by spirometry) or with current
smoking status or total lifetime cigarette consumption. We conclude that
measurement of urine desmosine may not be useful as an indirect measure-
ment of elastolysis in cigarette smokers."
HUNTER, E., SLONEKER, S.D. & KOSTENBAUDER, H.B., University of Kentucky
"Influence of chronic cigarette smoke exposure on the uptake and efflux of
imipramine in the isolated perfused rat lung." (Drug Metabolism and
Disposition 11/4: 361-5, 1983)
"The pulmonary uptake and efflux of imipramine was determined in
lungs removed from cigarette smoke-exposed and~nonexposed rats. Using an
isolated perfused lung preparation, the lung was perfused for 220 sec with
medium containing 2.5 x 10-7 M imipramine, followed by a 28-min drug-free
perfusion. There was no significant difference (P ,~0.05) between either
the rate or the amount of imipramine accumulated in the smoke-expose6and
nonexposed animals. During the drug-free perfusion, the previously accu-
mulated'.imipramine was released'.from~two distinct pools (El and E2). Cal-
culation~of the total amount of effluxable imipramine indicated!that in
the nonexposed animals approximately 30% of the amount taken up did not
efflux at a measurable rate but formed a 'noneffluxable' pool. In the
smoke-exposed animals, however, all of the accumulated imipramine appeared
to be effluxable. These d'ata demonstrate that there may be components of
cigarette smoke
which
are sequestered by
lung tissue at the
binding
sites
associatediwith the noneffluxable pool of imipramine. The presence in
arette smoke of components possessing such high pulmonary affinity may
a factor in
discussed."
cigarette smoke-mediated lung damage; this:possibility is
C
~

5.
(
TAGER, I.B., WEISS, S.T., MUNOZ, A., ROSNER, B. & SPEIZER, F.E., Channing
Laboratory, Boston, Massachusetts
"Longitudinal study of the effects of maternal smoking on pulmonary function
in children." (New England Journal of Medicine 309/12: 699-703, September 22,
1983)
"We investigated the effects of maternal cigarette smoking on pul-
monary function in a cohort of children and adolescents observed prospectively
for seven years. A multivariate analysis revealed that after correction for
previous forced expiratory volume in one second (FEV1), age, height, change
in height, and cigarette smoking in the child or adolescent, maternal cig-
arette smoking significantly lowered the expected average annual increase in
FEV1 (P = 0.015). On the basis of this analysis, it is estimated that if
two children have the same initial FEV1, age, height, increase in height, and
personal cigarette-smoking history, but the mother of one has smoked through-
out the child"s life whereas the mother of the other has not, the difference
in the change in FEV1 over time in the exposed child, as compared with that
in the unexposed child, will be approximately 28, 51, and 101 ml after one,
two, and five years, respectively, or a reduction of 10.7, 9.5, and 7.0 per
cent, respectively, in the expected increase. These results suggest that
passive exposure to maternal cigarette smoke may have important effects on
the development of pulmonary function~ in child'ren."
[N = 2,860]
(
3. PREGNANCY
FORSS, M., LEHTOVIRTA, P., RAURAMO, I. & I:ARINIEMI, V., Helsinki, Finland
"Midtrimester fetal heart rate variability and maternal hemodynamics in
association with smoking." (American Journal of Obstetrics and Gynecology
146/6: 693-5, July 15, 1983)
"Maternal heart rate (MHR), blood pressure (BP), the differential
index (DI) describing the short-term component of fetal heart rate (FHR)
variability, and the interval index (II) describing the long-term component
were measure&in eight subjects in the midtrimester before, during, and after
the mothers smoked a standard cigarette. The analyses of FHR variability
were performed by an 'on-line' method with an abdominal fetal electro-
cardiogram used as a triggering signal and with~alsample time of 1 minute.
An increase of MHR, FHR', and BP with a concomitant decrease of II was ob-
served. Unlike our findings regarding the third trimester, no significant
change of DI was observed. A correlation analysis reveale&fetomaternal
hemodynamic relationships different from~those in the third trimester:
There was a negative correlation between DI and FHR:(pc 0.01) and between
DI and MHR' (p < 0.01). There was a positive correlation between FHR and
bLHR (p < 0.001). Unlike our findings regarding the third trimester, no cor-
relation was found between DI and BP or between II and MHR. We suggest that
the midtrimester fetus shows the narcotic effect (decrease of II) of one ~
cigarette, as does the term~fetus, but fails to show the hypoxic effect ~
(decrease of DI), which has been observed in the term fetus." ~j
w
~
~
,

6.
BUREAU, M.A., SHAPCOTT, D., BERTHIAU*'IE, Y., MONETTE, J~., BLOUIN, D~.,
BLANCHARD, P. & BEGIN'., R., University of Sherbrooke, Montreal, Canada.
"Maternal cigarette smoking andifetal oxygen transport: A study of P50,
2,3-diphosphoglycerate, total hemoglobin, hematocrit, and type F hemoglobin
in fetal blood." (Pediatrics 72/1: 22-6, July 1983)
"The current study was undertaken to determine whether the 02
carrying capacity of newborns born to mothers who smoke can accommodate to
carbon monoxide poisoning to compensate for the potential tissue hypoxia
induced by CO. From a cohort of 1,222 women and newborn infants the total
hemoglobin concentration, hematocrit, and carboxyhemoglobin (HbCO) were
measured and analyzed with regard to the maternal HbCO level and the number
of cigarettes smoked per d'ay. Also, for 100 pairs of mothers, of whom 50
were smokers and 50 nonsmokers, and their newborns, measurements were made
of the intraerythrocyte concentration of 2,3-diphosphoglycerate (2,3'-DPG),
the hemoglobin concentration, and the affinity of hemoglobin for oxygen by
determination of 02 tension~for 50% of Hb-02 saturation (P50). The results
showed no significant relationship between smoking,habits of mothers and
their levels of hemoglobin, P50, and'2,3-DPG; only the hematocrit was
slightly increased in smoking mothers. However, in fetal blood a signif-
icant correlation was found between the number of cigarettes smoked per day
and levels of hemoglobin, hematocrit, and P50. The P50 decreased in re-
lationship to the increase inimaternal HbCO1. The P50,change was brought
about by an increase in hemoglobin F found in the fetuses of mothers who
smoked. Although al!l these changes were statistically significant, these
mechanisms of acclimatization to CO poisoning appeared trivial in magnitude.
It is concluded'that the human fetus does not have a biologic capacity to
accommodlate to maternal cigarette smoking, and therefore the fetus is
particularly susceptible to the adverse effects of cigarette smoking."
GOLDING, J. & BUTLER, N.R., Royal Hospital for Sick Children, Bristol,
England
"Maternal smoking and anencephaly." (British Medical Journal 287: 533-4,
August 201, 1983)~
"In 1979 Evans, Newcombe, and Campbell published a valuable
analysis of the Cardiff Birth Survey, showing little association between
maternal smoking in pregnancy and most types of those congenital defects
which are recognized neonatally. They did, however, find a weak associ-
ation with anencephaly (132 cases ) and spina bifida. (178 cases), even
after controlling for social class. We present an analysis of 4:91 preg-
nancies resulting in the birth of a singleton anencephalic....
"From the information~collected we calculated'the anencephalic
incidence per 1000 births if the mother smoked~at the start of pregnancy
as 2.89 (SE 01.19), which was significantly greater than that found if the
mother did not smoke (2.18 (SE 0.13); p-,0.05). The table shows that
there was some evidence for a trend with dose.
C
C

.
7.
(
(
"As in other studies, however, the incidence of anencephaly in
this survey rose sharply as social class fell, being 1.42 in classes I
and II, 2.39 in social class III, and 3.16 in classes IV and V. The pro-
portion of the control population of mothers smoking,in early pregnancy
also exhibited a trend with social class (32% in I and II, 41% in III, and
47% in IV and V). Indirect standardization for each of the five sociall
classes (table) resulted'lin no significant differences between the observed
and expected numbers in each smoking group."
TACHI, N:. & AOYAMA, M., Nagoya City University Medical School, Japan
"Effect of cigarette smoke and carbon monoxide inhalation by gravid rats
on the conceptus weight." (Bulletin of Environmental Contaminationiand
Toxicology 31/1: 85-92, July 1983)
"In summary, both continuous inhalation by [rat] mothers of cig-
arette smoke and carbon monoxide lowered the weight of the conceptus on
Days 14 and 21 of pregnancy, and the effect was more conspicuous in the
group expose&to cigarette smoke than that to carbommonoxide alone.
Therefore, the present study suggests that carbon monoxide is an important
but not sole factor responsible for the adverse influence of cigarette
smoke on the fetus. In addition, inhalation affected the fetus most
deleteriously when performed during the last third of pregnancy, i.e.
the phase of rapid fetal growth."
4. OTHER SYSTEMIC'CONDITIONS
AMES, B.N., University of California, Berkeley
"Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative
d'iseases."' (Science 221: 1256-64, September 23, 1983)
"The human diet contains a great variety of natural mutagens and
carcinogens, as well as many natural antimutagens and anticarci~nogens.
Many of these mutagens and carcinogens may act through the generation of
oxygen radicals. Oxygen radicals:may also play a major role as endogenous
initiators:of degenerative processes, such~as DNA damage and'mutation (and
promotion), that may be related to cancer, heart disease, and aging. Di-
etary intake of natural antioxidants could be an important aspect of the
body's defense mechanism against these agents. Many antioxidants are being
identified as anticarcinogens. Characterizing and optimizing such defense
systems may be an important part of a.strategy of minimizi,ng cancer and
other age-related diseases."
KOST, N., PACAKOVA, E. & ZOZULYA, A., Moscow, USSR
"A comparative study of the morphine effect on the level of cyclic AMP in
C
lymphocytes of smokers and nonsmokers." (Biologicali Psychiatry 18/7:
763-9, July 1983) (.J
~
~ "A study of the effect of morphine on the level of cAMP in the ~
W
lymphocytes of peripheral blood in smokers and nonsmokers was carried out. N
rA
C~

8'.
It was shown that morphine enhances the activity of ad'enylate cyclase,
and that this effect can~be abolished by naloxone. The dependence of the
enzyme activity on the concentration of morphine is complex. The maximal
effect of the investigate&opiate on the level of cAMP in lymphocytess
occurs among smokers at a tenfoldiconcentration comparediwith nonsmokers.
On the basis of our data two suggestions are made: (i) there are opiate
receptors on lymphocytes with a mechanism of action connected with the
regulation of adenylate cyclase activity; (ii) smoking develops tolerance
to morphine at the level of the opiate-dependent adenyliate cyciase of
lymphocytes."
[N = six smokers, six nonsmokers]
MITTLER, J.C., POGACH; L. & ERTEL, N.H., Veterans Adtninistration Medical
Center, East Orange, New Jersey
"Effects of chronic smoking on testosterone metabolism in dogs." (Journal
of Steroid!Biochemistry 18/6: 759-63, June 1983)
"The effects of long-term cigarette smoking on androgen hydroxy-
lases and peripheral hormones were studied in male beagles. In the testis,
chronic smoking of high nicotine/tar cigarettes was associated'with decreased~
activity of the 7~>-hydroxylase active on testosterone (68% of control,
P'< 0.05) . Testicular 6,~-,and 16='. -hydro::ylases were not altered. The hepatic
androgen 6-hy.droxylase activity in control animals was approximately 6
times the testis levels and was stimulatedimarkedly by smoking. This increase
ranged from 221% imthe low nicotine/tar group (P < 0.02) to 304% in the
high~nicotirne/'tar group (P ,;~0.006). Serum testosterone levels were reduced
to 54% of control (P ,1'0.02) and prostate size to 44% (P,, 0.001)' of control
withiheavy smoking. Serum~LH levels were elevated with smoking. These re-
sults suggest that chronic cigarette smoking increased hepatic metabolism
of testosterone. In addition~, serum testosterone levels and prostate size
decreased and LH levels increased. Whether the hepatic and'the endocrine
effects are causally related cannot be determined from this preliminary study."
FRITHIOF, L., ANNEROTH, G., LASSON, Ui. & SEDERHOL.^1, C., Karolinska Hospital,
Stockholm, Sweden
"The snuff-inducedilesion. A clinical and morphological study of a Swedish
material." (Act&Odontological Scandinavica 41/3: 53-64, 1983)
"Snuff-ind'2iced oral lesions were studied clinically, histologically
and'by electron miczvscopy. The material was collected from 21 male snuff
users. The lesions had a characteristic whitish appearance with a wrinkled
swollen texture and'the most common localization was in the vestibular area
of the upper jaw. In two cases gingival retraction was observed!. The light-
microscopical examination showed a mild epitheliial dysplasia in five cases.
No carcinoma in situ or invasive carcinom&was recognized'. In some of the
cases ultrastructural changes irn the basement lamina region, such~as defects
of the basement lamin&and the occurrence of basal cell processes in the
connective tissue, were observed. Odland bodies were seen in the epithelium.
C
C
e
t

9.
C
C
In the connective tissue filamentous material of unknown nature was found.
The ultrastructure of the filamentous material suggested that it might be
amyloid. In summary, snuff-induced lesions should be diagnosedl, patients
should be informed and made to quit the habit, and remaining,lesions should
be foll!owe&up regularly."
McCREDIE, Mi., STEWART, J.H. & FORD, J.M., Westmead Hospital, New South Wales,
Australia
"Analgesics and tobacco as risk factors for cancer of the ureter and renal
pelvis." (Journal of Urology 130/1: 28-30, July 1983)
"In alcase-control study of 36 men with~cancer of the ureter and
307 male controls withithe same age distribution tobacco smoking conferred
a relative risk for this cancer of 2.9, whereas consumption of analgesics
of any kind didinot increase the risk. The relative risk for cancer of
the renal pelvis, determined for 29 men, was 2.4 for tobacco and 6.O for
phenacetin-contalining analgesics. Analgesics containing no phenacetin con-
ferred no increased risk for cancer at this site. Data for 13 women,with
ureteral cancer, 5 of whom had taken phenacetin, are presented but not
analyzed."
IVES, T.J., University of North Carolina, Chapel Hill
"Use of dimenhydrinate in the treatment of green tobacco sickness." (Drug
Intelligence and Clinical Pharmacy 17/7-8: 548-9, July/August 1983)
"A case of green tobacco sickness (GTS)~ in a 37-year-old male
migrant worker and~the use of dimenhydrinate in its treatment/prophylaxis
is presented. A brief discussion of the etiology and';symptomatology of
CTS is included. Dimenhydrinate is a useful over-the-counter product for
the treatment of this occupational illness in the tobacco-growing states
of the Southeast."
5. STATISTICS
MILLER, G.H'. & GERSTEIN, D.R., Edinboro, Pennsylvania
"The life expectancy of nonsmoking mem and women." (Public Health Reports
98/4: 343-49, July/August 1983).
"Survey data.were collected on the lifetime smoking habits of
adults in Erie County, Pa., as of 1972-74. In the survey interviews, 0
careful distinctions were made between respondents who had formerly smoked w
and respondents who had never smoked. The survey data were combined withi
~
data:collected fromisurviving relatives about the smoking habits of people ~
who had died in Erie County during the years 1972-74. After deaths attrib- w
utable to traumatic causes ~
(accidents, suicides, and homicides) were removed,
~
life tables were calculated for male and female nonsmokers over age 30. The
resulting life expectancy figures for nonsmoking men an&women of parallel
age were virtually identical. Thus, differential rates of cigarette smoking
are apparently the overwhelming cause for the male-female longevity difference.

10.
Actuarial tables should be divided by smoking behavior to reflect this
finding. The results of the study suggest that the present longevity
difference between men and women will disappear."
[N = 2195]
6. NICOTINE
HENNINGFIELD, J.E., & JASINSKI, D.R., NIDA, Addiction Research Center,
Baltimore, Maryland
"Humanipharmacology of nicotine." (Psychopharmacology Bulletin 19/3:
413-5, 1983)
"Subjects were male cigarette smokers between 18 and!50 years
of age, who resided for 4 to 12'weeks at the clinical pharmacology re-
search unit of the Addiction Research Center in Baltimore. Except as noted,
subjects had histories of use andiabuse of a variety of drugs including
opioids, stimulants, and alcohol. In some studies, nicotine doses were
given by the controlled inhalation of smoke from research cigarettes, which
delivered a range of nicotine doses from about 0.4 to 2.9 mg (Federal Trade
Commission Method), while in other studies nicotine was given by 10-second
intravenous injections of nicotine tartrate in doses from 0.75 to 4.5 mg
(calculated'as the free base). In certain studies, subjects were pretreated
with the nicotinic antagonist, mecamylamine, in orally given doses ranging
from 2.5 to 10 mg. Drugs were given under double-blind conditions, with
each dose presented~on several occasions to each subject (crossover design)
according,to randomized block or Latin-square sequences. For each study,
deprivation of cigarette smoking and other substances such as food and
caffeine was held constant....
"Nicotine, in doses comparable to~those delivered by cigarette
smoking, is psychoactive, is a euphoriant, and serves as a reinforcer. These
are salient properties of drugs of abuse, such as morphine, cocaine, and
alcohol. These findings provide direct evidence that nicotine is a diepen-
dence-producing drug. Furthermore, these findings support the hypothesis
that the role of nicotine in cigarette smoking is similar to the role of
opium in morphine or heroin use, coca in cocaine use, and ethanol in~alco-
holic beverage consumption."
WESNES, K., WARBURTON, D.M. & MATZ, B., University of Reading, England
"Effects of nicotine on stimulus sensitivity andlresponse bias in a visual
vigilance task." (Neuropsychobiology 9/1: 41-4, January/February 1983)
"Signal detection~analysis was used to~examine the effects of nic- ~
otine on a visual vigilance task. Groups of light, heavy and non-smokers
performed the 80-min task on three separate occasions, and received dif- ~
ferent doses of nicotine each time. For all three types of smoker, nicotine ~
significantly counteracted the decrement in stimulus sensitivity which ~
occurred over time in the placebo condition, while having no effect on (p
response bias. We argue that nicotine prod'uced this effect by acting on
the central, cholinergic pathways controlling electrocortical arousal, and
therefore that these pathways play a role in the control of human information
processing....
(
(
c
~
